![](/img/cover-not-exists.png)
Efficacy and safety of BRAF inhibitors (BRAFi) +/- MEK inhibitors (MEKi) in BRAF mutant (BRAFm) advanced non-small cell lung cancer (NSCLC): findings from the real-life cohort
Dudnik, Elizabeth, Bar, Jair, Peled, Nir, Bshara, Elias, Kuznetsov, Teodor, Cohen, Aharon Yonathan, Shochat, Tzippy, Nechushtan, Hovav, Onn, Amir, Agbarya, Abed, Moskovitz, Mor, Keren, Shoshana, PopovLanguage:
english
Journal:
Clinical Lung Cancer
DOI:
10.1016/j.cllc.2019.03.007
Date:
April, 2019
File:
PDF, 1.09 MB
english, 2019